ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Yueming Zhang
Matched on ORCID iD 0000-0003-3625-3280; OpenAlex author ID A5101952040. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Pancreatic surgery is safe in elderly patients with PDAC. Co-author DOI 10.1186/s12877-025-05907-8↗
- Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis. First author DOI 10.3389/fonc.2022.789351↗
- Characteristics of bile microbiota in cholelithiasis, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer. Co-author PMID 35702117↗
- Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. Co-author DOI 10.1007/s10147-020-01782-y↗
- Positive Impact of Intraoperative Epidural Ropivacaine Infusion on Oncologic Outcomes in Pancreatic Cancer Patients Undergoing Pancreatectomy: A Retrospective … Co-author DOI 10.7150/jca.57661↗
- Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection. First author DOI 10.1093/jjco/hyaa035↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yaolin Xu · 5 shared papers, 2020–2025 · strength 0.84
- Paper Pancreatic surgery is safe in elderly patients with PDAC. DOI 10.1186/s12877-025-05907-8↗
- Paper Positive Impact of Intraoperative Epidural Ropivacaine Infusion on Oncologic Outcomes in Pancreatic Cancer Patients Und… DOI 10.7150/jca.57661↗
- Paper Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis. DOI 10.3389/fonc.2022.789351↗
- Dansong Wang · 4 shared papers, 2020–2025 · strength 0.67
- Paper Pancreatic surgery is safe in elderly patients with PDAC. DOI 10.1186/s12877-025-05907-8↗
- Paper Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis. DOI 10.3389/fonc.2022.789351↗
- Paper Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. DOI 10.1007/s10147-020-01782-y↗
- Wenchuan Wu · 3 shared papers, 2020–2025 · strength 0.51
- Paper Pancreatic surgery is safe in elderly patients with PDAC. DOI 10.1186/s12877-025-05907-8↗
- Paper Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. DOI 10.1007/s10147-020-01782-y↗
- Paper Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical res… DOI 10.1093/jjco/hyaa035↗
- Wenhui Lou · 3 shared papers, 2020–2021 · strength 0.44
- Paper Positive Impact of Intraoperative Epidural Ropivacaine Infusion on Oncologic Outcomes in Pancreatic Cancer Patients Und… DOI 10.7150/jca.57661↗
- Paper Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. DOI 10.1007/s10147-020-01782-y↗
- Paper Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical res… DOI 10.1093/jjco/hyaa035↗
- Tiantao Kuang · 3 shared papers, 2020–2022 · strength 0.42
- Paper Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis. DOI 10.3389/fonc.2022.789351↗
- Paper Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer. DOI 10.1007/s10147-020-01782-y↗
- Paper Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical res… DOI 10.1093/jjco/hyaa035↗
- Xuefeng Xu · 2 shared papers, 2021–2022 · strength 0.30
- Dayong Jin · 2 shared papers, 2021–2022 · strength 0.30
- Wenhui Lou · 1 shared paper, 2025 · strength 0.25
- Liang Liu · 1 shared paper, 2025 · strength 0.25
- Lei Zhang · 1 shared paper, 2025 · strength 0.25
- Xiaodan Han · 1 shared paper, 2021 · strength 0.17
- Wannan Chen · 1 shared paper, 2021 · strength 0.17
- Wenhui Lou · 1 shared paper, 2022 · strength 0.16
- Zhengqi Li · 1 shared paper, 2022 · strength 0.14
- Shun He · 1 shared paper, 2022 · strength 0.14
- Xudong Liu · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.